CYP3A4 and breast carcinoma: Breast cancer spheroids (BT474, HCC1954, EFM192A) were more resistant to the drugs neratinib and docetaxel, due to the increase in both CYP3A4 activity and the expression of two membrane transporters associated with resistance (PGP and BCRP).